These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2336874)

  • 1. Characterization of the adjuvant-free serological response to protein antigens coupled to antibodies specific for class II MHC determinants.
    Carayanniotis G; Barber BH
    Vaccine; 1990 Apr; 8(2):137-44. PubMed ID: 2336874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.
    Carayanniotis G; Barber BH
    Nature; 1987 May 7-13; 327(6117):59-61. PubMed ID: 3472080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of synthetic peptides by anti-class II MHC monoclonal antibodies induces specific adjuvant-free IgG responses in vivo.
    Carayanniotis G; Vizi E; Parker JM; Hodges RS; Barber BH
    Mol Immunol; 1988 Sep; 25(9):907-11. PubMed ID: 2850498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the adjuvant-independent antibody response to immunotargeting. Target structure dependence, isotype distribution, and induction of long term memory.
    Skea DL; Barber BH
    J Immunol; 1993 Oct; 151(7):3557-68. PubMed ID: 8376792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant-independent immunization by immunotargeting antigens to MHC and non-MHC determinants in vivo.
    Carayanniotis G; Skea DL; Luscher MA; Barber BH
    Mol Immunol; 1991 Mar; 28(3):261-7. PubMed ID: 1708106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies.
    Estrada A; McDermott MR; Underdown BJ; Snider DP
    Vaccine; 1995 Jul; 13(10):901-7. PubMed ID: 7483762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice.
    Snider DP; Underdown BJ; McDermott MR
    Immunology; 1997 Mar; 90(3):323-9. PubMed ID: 9155636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of conventional adjuvants and 'adjuvant-free' monoclonal antibody targeting for stimulating antibody responses against a conjugate of luteinizing hormone releasing hormone and avidin.
    Tiong GK; Gill HS; Lofthouse S; Puri NK
    Vaccine; 1993; 11(4):425-30. PubMed ID: 8470426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the structure of processed antigen by using biotin and avidin. MHC-dependent inhibition of responses to selected biotinyl-insulin derivatives.
    Jensen PE; Wilkinson KD
    J Immunol; 1989 Dec; 143(11):3423-9. PubMed ID: 2685118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo.
    Frleta D; Demian D; Wade WF
    Int Immunopharmacol; 2001 Feb; 1(2):265-75. PubMed ID: 11360928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotypes of anti-major histocompatibility complex antibodies.
    Sachs DH; Bluestone JA; Epstein SL; Rabinowitz R
    Ann N Y Acad Sci; 1983; 418():265-71. PubMed ID: 6424530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells.
    Wallny HJ; Sollami G; Karjalainen K
    Eur J Immunol; 1995 May; 25(5):1262-6. PubMed ID: 7774629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant antibodies containing an engineered B-cell epitope capable of eliciting conformation-specific antibody responses.
    Cook J; Barber BH
    Vaccine; 1995 Dec; 13(18):1770-8. PubMed ID: 8701592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for the generation of monoclonal antibodies against rare cell-surface molecules.
    Kayyem JF; Roman JM; Von Boxberg Y; Schwarz U; Dreyer WJ
    Eur J Biochem; 1992 Aug; 208(1):1-8. PubMed ID: 1511678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product.
    Marrack P; Endres R; Shimonkevitz R; Zlotnik A; Dialynas D; Fitch F; Kappler J
    J Exp Med; 1983 Oct; 158(4):1077-91. PubMed ID: 6413636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.